Search Contract Opportunities

Service Agreement for multiple Opera Phenix, Operetta CLS, and associated equipment

ID: 75N95025R00044 • Type: Presolicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Draft a response outline indicating that my company is also capable of performing this sole source work
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

NOTICE OF INTENT to Sole Source

SOLICITATION NUMBER: 75N95025R00044

TITLE: Service Agreement for multiple Opera Phenix, Operetta CLS, and associated equipment

CLASSIFICATION CODE: J066 MAINT/REPAIR/REBUILD OF EQUIPMENT INSTRUMENTS AND LABORATORY EQUIPMENT

NAICS CODE: 811210 - Electronic and Precision Equipment Repair and Maintenance

RESPONSE DATE: August 14, 2025, at 09:00 AM EDT

PRIMARY POINT OF CONTACT:

Patricia da Silva

patricia.dasilva@nih.gov

Phone: 301.827.1980

DESCRIPTION:

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with Revvity Health Sciences, Inc., 68 Elm Street, Hopkinton, MA 01748-1602, for the preventative maintenance services on existing Operetta CLS (1), Opera Phenix (6), Flex 750 and robot fixed cell units at NCATS. The circumstances that limit the availability is that Revvity is the only entity authorized to supply genuine parts for this equipment and to repair this equipment.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS

The intended procurement is classified under NAICS code 811210 - Electronic and Precision Equipment Repair and Maintenance with a Size Standard of $34 million.

REGULATORY AUTHORITY

This acquisition is for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5 Simplified Procedures for Certain Commercial Products and Commercial Services, U.S.C 41 1901 Simplified acquisition procedures, the statutory authority of 41 USC 3304 Use of noncompetitive procedures.

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2025-04 dated May 12, 2025.

This acquisition is conducted under the procedures as prescribed in FAR subpart 13.5 Simplified Procedures for Certain Commercial Products and Commercial Services and FAR subpart 12 Acquisition of Commercial Products and Commercial Services at an amount exceeding the SAT, and not exceeding $7.5 million.

DESCRIPTION OF REQUIREMENT

PURPOSE AND OBJECTIVES:

The National Center for Advancing Translational Sciences (NCATS) Division of Preclinical Innovation (DPI) requires a service maintenance agreement to support our existing high throughput microplate-based automated imaging systems (Operetta CLS; 1), the high throughput confocal imaging system (Opera Phenix; 6), and the Flex 750 plate handler and Robot Fixed Cell.

These instruments are used throughout NCATS DPI for a wide variety of uses, including monitoring and recording cellular-level biological activities or changes in living cells, measuring and analyzing stem cell growth and differentiation, phenotypic screening and high content screening to measure changes in fluorescence and colorimetric data in tissues in response to drug treatments.

This service agreement would cover critical, highly utilized instruments that will allow continuous service from this equipment, thus preventing costly work stoppages and protecting the integrity of our research.

Project requirements: Please see STATEMENT OF WORK (SOW) attached to this posting.

ESTIMATED PERIOD OF PERFORMANCE:

Coverage period of service agreement is 12 months.

CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION

The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Revvity Health Sciences, Inc. is the only sole proprietor of these systems. Only this suggested source can furnish the requirements, to the exclusion of other sources, because only Revvity is authorized to work on the systems.

The intended source is:

Revvity Health Sciences, Inc.

68 Elm St

Hopkinton, MA 01748

CLOSING STATEMENT

THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by the closing date and time of this announcement and must reference the solicitation number, 75N95025R00044. Responses must be submitted electronically to Patricia da Silva, Contract Specialist, at patricia.dasilva@nih.gov and Christine Frate, Contracting Officer, at christine.frate@nih.gov. U.S. Mail and fax responses will not be accepted.

Background
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with Revvity Health Sciences, Inc. for preventative maintenance services on existing Operetta CLS, Opera Phenix, Flex 750, and robot fixed cell units.

Revvity is the only entity authorized to supply genuine parts and repair this equipment, which is critical for NCATS's research activities.

Work Details
The service agreement includes:
- Preventive maintenance visits and adjustments for Operetta CLS (1), Opera Phenix (6), Flex 750 plate handler, and Robot Fixed Cell.
- At least one preventive maintenance visit by certified Revvity technicians.
- Performance verification during maintenance to ensure systems meet manufacturer specifications.
- Calibration of detectors and lasers for accurate results.
- On-site repair services by certified technicians in case of malfunctions.
- Priority response time for service calls within 24-48 hours to minimize downtime.
- Use of genuine Revvity replacement parts as needed.
- Access to 24/7 technical support via phone and email.
- Regular software updates to ensure compatibility with new features.
- Detailed service reports after each visit documenting work performed and system performance.

Period of Performance
The coverage period of the service agreement is 12 months, optimally from September 2, 2025, through September 1, 2026, with options for two additional years.

Place of Performance
The contract will be performed at the National Center for Advancing Translational Sciences (NCATS).

Overview

Response Deadline
Aug. 14, 2025, 9:00 a.m. EDT Past Due
Posted
July 30, 2025, 10:23 a.m. EDT
Set Aside
None
Place of Performance
United States
Source

Current SBA Size Standard
$34 Million
Pricing
Likely Fixed Price
Est. Level of Competition
Sole Source
Est. Value Range
Experimental
<$250,000 (solicitation indicates Simplified Acquisition Procedures, which in most cases, applies to contracts expected to be less than $250K in value)
Odds of Award
40%
On 7/30/25 National Institute on Drug Abuse issued Presolicitation 75N95025R00044 for Service Agreement for multiple Opera Phenix, Operetta CLS, and associated equipment due 8/14/25. The opportunity was issued full & open with NAICS 811210 and PSC J066.
Primary Contact
Name
Patricia da Silva   Profile
Phone
None

Secondary Contact

Name
Christine Frate   Profile
Phone
None

Documents

Posted documents for Presolicitation 75N95025R00044

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Incumbent or Similar Awards

Contracts Similar to Presolicitation 75N95025R00044

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation 75N95025R00044

Similar Active Opportunities

Open contract opportunities similar to Presolicitation 75N95025R00044

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NATIONAL INSTITUTES OF HEALTH NIDA
FPDS Organization Code
7529-75N950
Source Organization Code
100189048
Last Updated
July 30, 2025
Last Updated By
patricia.dasilva@nih.gov
Archive Date
Aug. 29, 2025